Neuroscience
Dystonia
100%
Serine
96%
Ataxia
70%
Myoclonus
62%
Stereotypic Movement Disorder
56%
Metabolic Pathway
44%
Amino Acid
41%
Central Nervous System
26%
Phosphoglycerate Dehydrogenase
24%
Non-Motor Symptoms
22%
Anabolism
20%
Serotonergic
17%
In Vivo
15%
NMDA Receptor
15%
Eicosanoid Receptor
14%
Aspartic Acid
12%
Microcephaly
11%
Basal Ganglia
11%
Psychomotor Retardation
11%
Eye Movement Disorder
10%
Hurler Syndrome
10%
Magnetic Resonance Imaging
10%
Electrical Brain Stimulation
10%
Hematopoietic Stem Cell
10%
Dementia Praecox
10%
Proline
10%
Serotonin
9%
Fibroblast
9%
Dextro Serine
9%
Tic Disorder
9%
Stereotypy
9%
Cerebellum
9%
Agonist
8%
Nuclear Magnetic Resonance Spectroscopy
8%
Parkinsonism
7%
Neurometabolic Disease
7%
Mitochondrial DNA
7%
Brain Injury
7%
Glutamic Acid
7%
Neurotransmission
6%
Phenylalanine
6%
D-Amino Acid Oxidase
6%
Liquid Chromatography-Mass Spectrometry
6%
Genome-Wide Association Study
6%
Gene Mutation
6%
Magnetic Resonance Imaging
6%
Ischemia
6%
Dopaminergic
6%
Dextro Amino Acid
6%
GTP Cyclohydrolase I
6%
Medicine and Dentistry
Disease
97%
Stereotypic Movement Disorder
63%
Inborn Error of Metabolism
50%
Myoclonus
41%
Diagnosis
37%
Ataxia
33%
Systematic Review
32%
Symptom
27%
Dystonia
26%
Water-Electrolyte Imbalance
25%
Hurler Syndrome
21%
Serine
20%
Quality of Life
20%
Epileptic Seizure
17%
Lafora Disease
16%
Phosphoglycerate Dehydrogenase
16%
Niemann-Pick Disease
13%
Biological Marker
12%
Magnetic Resonance Imaging
12%
Cerebrospinal Fluid
12%
Respiratory Chain
12%
Lysosomal Storage Disease
11%
Neurologic Disease
11%
Amino Acid
10%
Eye Movement Disorder
10%
Hematopoietic Stem Cell Transplantation
10%
Aciduria
10%
Next Generation Sequencing
10%
Diagnostic Procedure
10%
Storage Disease
10%
Neonatal Infant
10%
Screening
10%
Neonate
9%
Phenotype
8%
Microcephaly
8%
Clinician
8%
Parkinsonism
8%
Bleeding
8%
Clinical Feature
7%
Stem Cell Therapy
7%
Newborn Screening
7%
Down Syndrome
7%
Metabolite
7%
Cholestasis
7%
Psychomotor Development
7%
Differential Diagnosis
7%
Brain Disease
7%
Hypoplasia
7%
Outpatient
6%
Genetic Disorder
6%
Keyphrases
Dehydrogenase Deficiency
50%
Glyceraldehyde-3-phosphate Dehydrogenase
42%
Movement Disorders
39%
Inborn Errors of Metabolism
32%
Glycine
31%
Dystonia
28%
Amino Acids
27%
Cerebrospinal Fluid
27%
Seizure
21%
Serine Biosynthesis
19%
Congenital Microcephaly
19%
Central Nervous System
18%
Eye Movement Disorders
16%
Neurometabolic Disorders
16%
Early Onset Ataxia
16%
Hurler Syndrome
16%
Psychomotor Retardation
15%
Next-generation Sequencing
15%
Serine Deficiency
13%
B6 Vitamers
13%
Deficiency Diseases
12%
Ataxia
12%
North Sea Progressive Myoclonus Epilepsy
10%
Vitamin B6
10%
In(III)
10%
Progressive Myoclonus Ataxia
10%
N-methyl-D-aspartate Receptor (NMDAR)
10%
Niemann-Pick Type C
10%
Late-onset
9%
Intractable Seizures
9%
Load Test
9%
Hypoglycemia
8%
Neurological Symptoms
8%
Hypomyelination
8%
Non-motor Symptoms
7%
Interobserver Agreement
7%
Dopa-responsive Dystonia
7%
Diagnostic Algorithm
7%
Pyridoxal 5′-phosphate
7%
Pyridoxine
7%
Clinical Diagnostics
7%
Clinical Spectrum
7%
Co-agonist
7%
4-Pyridoxic Acid
7%
Diagnostic Process
6%
Healthy children
6%
White Matter Abnormalities
6%
Genetic Testing
6%
Differential Diagnosis
6%
Genetic Causes
6%
